| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | CUL4B SNRPGP15 ATR RSL1D1 DHX37 EIF5B UTP20 CHD7 XRCC5 SNRPG RPL7 | 5.29e-06 | 515 | 81 | 11 | GO:0022613 |
| GeneOntologyBiologicalProcess | DNA metabolic process | CUL4B PARP1 FZR1 SP100 SETD2 ARID1B TCF7 WIZ ATR CCNE2 POLG EXO1 SMOC2 XRCC5 RAC1 | 1.76e-05 | 1081 | 81 | 15 | GO:0006259 |
| GeneOntologyBiologicalProcess | ribosome biogenesis | 5.22e-05 | 336 | 81 | 8 | GO:0042254 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 5.23e-05 | 168 | 81 | 6 | GO:0000723 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 7.21e-05 | 178 | 81 | 6 | GO:0006261 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 9.10e-05 | 60 | 81 | 4 | GO:0045005 | |
| GeneOntologyBiologicalProcess | telomere organization | 1.33e-04 | 199 | 81 | 6 | GO:0032200 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.48e-05 | 35 | 80 | 4 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 2.06e-05 | 38 | 80 | 4 | PS00690 | |
| Domain | PEHE | 5.42e-05 | 3 | 80 | 2 | SM01300 | |
| Domain | MAP1 | 5.42e-05 | 3 | 80 | 2 | IPR026074 | |
| Domain | PEHE_dom | 5.42e-05 | 3 | 80 | 2 | IPR029332 | |
| Domain | PEHE | 5.42e-05 | 3 | 80 | 2 | PF15275 | |
| Domain | HMG_box | 7.79e-05 | 53 | 80 | 4 | PF00505 | |
| Domain | HMG_BOX_2 | 8.39e-05 | 54 | 80 | 4 | PS50118 | |
| Domain | HMG | 8.39e-05 | 54 | 80 | 4 | SM00398 | |
| Domain | - | 9.02e-05 | 55 | 80 | 4 | 1.10.30.10 | |
| Domain | HMG_box_dom | 1.73e-04 | 65 | 80 | 4 | IPR009071 | |
| Domain | - | 1.80e-04 | 5 | 80 | 2 | 2.40.290.10 | |
| Domain | SPOC-like_C_dom | 1.80e-04 | 5 | 80 | 2 | IPR016194 | |
| Domain | Helicase_C | 1.15e-03 | 107 | 80 | 4 | PF00271 | |
| Domain | HELICc | 1.15e-03 | 107 | 80 | 4 | SM00490 | |
| Domain | Helicase_C | 1.19e-03 | 108 | 80 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 1.23e-03 | 109 | 80 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.23e-03 | 109 | 80 | 4 | PS51192 | |
| Domain | DEXDc | 1.23e-03 | 109 | 80 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.28e-03 | 110 | 80 | 4 | IPR014001 | |
| Domain | CysPc | 1.83e-03 | 15 | 80 | 2 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 1.83e-03 | 15 | 80 | 2 | IPR001300 | |
| Domain | Peptidase_C2 | 1.83e-03 | 15 | 80 | 2 | PF00648 | |
| Domain | CALPAIN_CAT | 1.83e-03 | 15 | 80 | 2 | PS50203 | |
| Domain | Globin-like | 2.09e-03 | 16 | 80 | 2 | IPR009050 | |
| Domain | Cyclin_C | 2.36e-03 | 17 | 80 | 2 | PF02984 | |
| Domain | DUF1605 | 2.36e-03 | 17 | 80 | 2 | IPR011709 | |
| Domain | Cyclin_C-dom | 2.36e-03 | 17 | 80 | 2 | IPR004367 | |
| Domain | OB_NTP_bind | 2.36e-03 | 17 | 80 | 2 | PF07717 | |
| Domain | Cyclin_C | 2.36e-03 | 17 | 80 | 2 | SM01332 | |
| Domain | HA2 | 2.65e-03 | 18 | 80 | 2 | SM00847 | |
| Domain | HA2 | 2.65e-03 | 18 | 80 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 2.65e-03 | 18 | 80 | 2 | IPR007502 | |
| Domain | - | 3.27e-03 | 20 | 80 | 2 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 3.27e-03 | 20 | 80 | 2 | IPR001279 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M | 9.58e-06 | 11 | 56 | 3 | M47573 | |
| Pathway | WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK | 1.11e-04 | 120 | 56 | 5 | M40049 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CUL4B SNRPGP15 PRAM1 ELOA PARP1 SETD2 ARID1B BBX WIZ MAP1B CDK12 RSL1D1 ZC3H15 STAU2 CAST RBM15B EIF5B FARSB MSL1 CHD7 XRCC5 SNRPG | 3.69e-16 | 954 | 82 | 22 | 36373674 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ELOA PARP1 SETD2 ARID1B BBX WIZ MAP1A MAP1B CDK12 ZC3H15 DHX37 APOOL STAU2 RBM15B EIF5B CHD2 CHD7 XRCC5 SNRPG DHX8 DNMT3A | 5.62e-14 | 1082 | 82 | 21 | 38697112 |
| Pubmed | CEP350 SNRPGP15 ELOA PARP1 GZF1 CDK12 RSL1D1 DHX37 MCM3AP STAU2 RBM15B FARSB CHD2 MSL1 CHD7 PIPSL XRCC5 RPL7 PRRC2B RAC1 | 4.32e-11 | 1371 | 82 | 20 | 36244648 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ELOA PARP1 SETD2 WIZ MAP1A MAP1B CDK12 RSL1D1 ZC3H15 STAU2 CAST EIF5B FARSB XRCC5 HERC4 RPL7 PRRC2B | 5.37e-11 | 934 | 82 | 17 | 33916271 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL4B PACS1 ELOA SETD2 KANSL1 ATR CDK12 RSL1D1 CAST RBM15B ZBTB40 EXO1 EIF5B UTP20 CHD7 | 3.56e-10 | 774 | 82 | 15 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RYBP PARP1 SETD2 BBX WIZ KANSL1 ATR RSL1D1 RBM15B EXO1 UTP20 CHD2 MSL1 CHD7 XRCC5 SNRPG RPL7 DHX8 | 1.02e-09 | 1294 | 82 | 18 | 30804502 |
| Pubmed | MAPKAP1 RFTN1 SETD2 BBX GZF1 WIZ CDK12 ZC3H15 STAU2 RBM15B EIF5B FARSB UTP20 CHD2 MSL1 CHD7 SNRPG RAC1 DHX8 | 1.47e-09 | 1497 | 82 | 19 | 31527615 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ELOA PARP1 BBX WIZ DHX37 ZBTB40 CHD2 MSL1 CHD7 XRCC5 RAC1 DHX8 DNMT3A | 1.86e-09 | 608 | 82 | 13 | 36089195 |
| Pubmed | CUL4B MAP1B RSL1D1 DHX37 MCM3AP EIF5B UTP20 CHD2 CHD7 XRCC5 RPL7 PRRC2B DHX8 | 4.36e-09 | 653 | 82 | 13 | 22586326 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CEP350 WIZ MAP1A MAP1B RSL1D1 ZC3H15 DHX37 STAU2 CAST EIF5B SECISBP2 PRRC2B DHX8 | 1.48e-08 | 724 | 82 | 13 | 36232890 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.40e-08 | 283 | 82 | 9 | 30585729 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ELOA MAP1B CDK12 RSL1D1 DHX37 STAU2 RBM15B EXO1 FARSB UTP20 XRCC5 RPL7 DHX8 | 2.57e-08 | 759 | 82 | 13 | 35915203 |
| Pubmed | 1.44e-07 | 250 | 82 | 8 | 33536335 | ||
| Pubmed | RYBP ARID1B TCF7 BBX WIZ KANSL1 ZFHX4 ZNF608 RSL1D1 DHX37 STAU2 ZBTB40 MSL1 CHD7 XRCC5 PRRC2B | 1.96e-07 | 1429 | 82 | 16 | 35140242 | |
| Pubmed | 2.13e-07 | 483 | 82 | 10 | 36912080 | ||
| Pubmed | RYBP RFTN1 ELOA PARP1 SP100 BBX MAP1B ZNF608 RSL1D1 VPS13A EIF5B CHD2 MSL1 XRCC5 PRRC2B RAC1 | 2.21e-07 | 1442 | 82 | 16 | 35575683 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ELOA PARP1 FZR1 SP100 RSL1D1 ZC3H15 DHX37 STAU2 RBM15B EIF5B FARSB UTP20 XRCC5 RPL7 DHX8 | 2.22e-07 | 1257 | 82 | 15 | 36526897 |
| Pubmed | BBX GZF1 RSL1D1 MCM3AP STAU2 EIF5B UTP20 MSL1 XRCC5 RPL7 PRRC2B | 4.06e-07 | 655 | 82 | 11 | 35819319 | |
| Pubmed | 4.14e-07 | 396 | 82 | 9 | 26687479 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | PARP1 RSL1D1 ZC3H15 STAU2 RBM15B EIF5B UTP20 CHD2 XRCC5 RPL7 PRRC2B DHX8 | 4.21e-07 | 807 | 82 | 12 | 22681889 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 4.32e-07 | 398 | 82 | 9 | 35016035 | |
| Pubmed | PARP1 FZR1 KANSL1 CDK12 RSL1D1 ZC3H15 DHX37 STAU2 CAST EIF5B FARSB XRCC5 RPL7 | 4.35e-07 | 971 | 82 | 13 | 33306668 | |
| Pubmed | SNRPGP15 PARP1 ARID1B CDK12 RSL1D1 ZC3H15 STAU2 FARSB CHD2 CHD7 PIPSL XRCC5 SNRPG RPL7 | 4.82e-07 | 1153 | 82 | 14 | 29845934 | |
| Pubmed | 6.36e-07 | 417 | 82 | 9 | 36537216 | ||
| Pubmed | 6.62e-07 | 419 | 82 | 9 | 15635413 | ||
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 8.36e-07 | 431 | 82 | 9 | 33660365 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 8.46e-07 | 316 | 82 | 8 | 31665637 | |
| Pubmed | RYBP RSL1D1 DHX37 STAU2 EIF5B FARSB SECISBP2 SNRPG RPL7 PRRC2B DHX8 | 1.07e-06 | 723 | 82 | 11 | 34133714 | |
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 1.56e-06 | 150 | 82 | 6 | 30154076 | |
| Pubmed | 1.62e-06 | 83 | 82 | 5 | 28794006 | ||
| Pubmed | PRAM1 PARP1 ARID1B WIZ RSL1D1 ZC3H15 ZBTB40 EIF5B FARSB CHD7 SNRPG PRRC2B RAC1 | 1.80e-06 | 1103 | 82 | 13 | 34189442 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.28e-06 | 361 | 82 | 8 | 26167880 | |
| Pubmed | 2.65e-06 | 496 | 82 | 9 | 31343991 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PARP1 KANSL1 MAP1B RSL1D1 DHX37 MCM3AP FERMT1 EIF5B FARSB UTP20 CHD2 CHD7 XRCC5 RPL7 | 3.15e-06 | 1353 | 82 | 14 | 29467282 |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 3.59e-06 | 384 | 82 | 8 | 31059266 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | MAP1B CDK12 RSL1D1 DHX37 STAU2 EIF5B SECISBP2 XRCC5 SNRPG RPL7 | 4.49e-06 | 678 | 82 | 10 | 30209976 |
| Pubmed | 4.91e-06 | 183 | 82 | 6 | 36129980 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 7806212 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 12531386 | ||
| Pubmed | ATR-dependent pathways control hEXO1 stability in response to stalled forks. | 5.49e-06 | 2 | 82 | 2 | 18048416 | |
| Pubmed | Regulation of microtubule-associated protein 1B (MAP1B) subunit composition. | 5.49e-06 | 2 | 82 | 2 | 11002287 | |
| Pubmed | Poly(ADP-ribose) polymerase 1 regulates mitochondrial DNA repair in an NAD-dependent manner. | 5.49e-06 | 2 | 82 | 2 | 33482196 | |
| Pubmed | Staufen 2 regulates mGluR long-term depression and Map1b mRNA distribution in hippocampal neurons. | 5.49e-06 | 2 | 82 | 2 | 21508097 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 16996626 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 27582468 | ||
| Pubmed | Interaction between PARP-1 and ATR in mouse fibroblasts is blocked by PARP inhibition. | 5.49e-06 | 2 | 82 | 2 | 18691676 | |
| Pubmed | Neuronal abnormalities in microtubule-associated protein 1B mutant mice. | 5.49e-06 | 2 | 82 | 2 | 8577753 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 2355215 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 12460917 | ||
| Pubmed | The mouse and rat MAP1B genes: genomic organization and alternative transcription. | 5.49e-06 | 2 | 82 | 2 | 9615228 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 34074749 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 26895424 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 9199175 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 5.80e-06 | 410 | 82 | 8 | 26949251 | |
| Pubmed | 6.98e-06 | 713 | 82 | 10 | 29802200 | ||
| Pubmed | 7.09e-06 | 112 | 82 | 5 | 28416769 | ||
| Pubmed | PACS1 ARID1B RSL1D1 POLG CAST ZBTB40 FARSB CHD2 CHD7 ANKRD12 SUCO HERC4 | 8.80e-06 | 1084 | 82 | 12 | 11544199 | |
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 9.60e-06 | 56 | 82 | 4 | 26919559 | |
| Pubmed | 1.16e-05 | 451 | 82 | 8 | 30033366 | ||
| Pubmed | CUL4B SP100 SETD2 ARID1B WIZ ZFHX4 MAP1A ZNF608 CCNB3 ZC3H15 MCM3AP PRRC2B | 1.18e-05 | 1116 | 82 | 12 | 31753913 | |
| Pubmed | CUL4B SNRPGP15 PARP1 MAP1A MAP1B RSL1D1 ZC3H15 WDR87 EIF5B FARSB PIPSL XRCC5 RPL7 | 1.41e-05 | 1335 | 82 | 13 | 29229926 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 23881099 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 15545322 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 20098424 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 36471438 | ||
| Pubmed | MAP1B regulates axonal development by modulating Rho-GTPase Rac1 activity. | 1.64e-05 | 3 | 82 | 2 | 20719958 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 2470876 | ||
| Pubmed | Microtubule-associated proteins, MAP 1A and MAP 1B, interact with F-actin in vitro. | 1.64e-05 | 3 | 82 | 2 | 7908020 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 24664738 | ||
| Pubmed | G-quadruplexes in the BAP1 promoter positively regulate its expression. | 1.64e-05 | 3 | 82 | 2 | 29787736 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 16478718 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 38721777 | ||
| Pubmed | ATM Kinase Is Required for Telomere Elongation in Mouse and Human Cells. | 1.64e-05 | 3 | 82 | 2 | 26586427 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 30277262 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 10400681 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 23152929 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 1.71e-05 | 626 | 82 | 9 | 33644029 | |
| Pubmed | A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. | 1.74e-05 | 65 | 82 | 4 | 27453043 | |
| Pubmed | 1.89e-05 | 634 | 82 | 9 | 34591612 | ||
| Pubmed | 1.98e-05 | 638 | 82 | 9 | 31182584 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.00e-05 | 351 | 82 | 7 | 38297188 | |
| Pubmed | 2.16e-05 | 645 | 82 | 9 | 25281560 | ||
| Pubmed | A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers. | 2.47e-05 | 24 | 82 | 3 | 16620772 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PARP1 ATR RSL1D1 ZC3H15 DHX37 RBM15B EIF5B FARSB UTP20 XRCC5 RPL7 RAC1 DHX8 | 2.79e-05 | 1425 | 82 | 13 | 30948266 |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 2.91e-05 | 150 | 82 | 5 | 28242625 | |
| Pubmed | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. | 3.28e-05 | 4 | 82 | 2 | 26637798 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 17187679 | ||
| Pubmed | Characterization of the calcium-dependent proteolytic system in a mouse muscle cell line. | 3.28e-05 | 4 | 82 | 2 | 11952156 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 15650754 | ||
| Pubmed | Mutations in the microtubule-associated protein 1A (Map1a) gene cause Purkinje cell degeneration. | 3.28e-05 | 4 | 82 | 2 | 25788676 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 9873017 | ||
| Pubmed | Structural basis for MOF and MSL3 recruitment into the dosage compensation complex by MSL1. | 3.28e-05 | 4 | 82 | 2 | 21217699 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 37227155 | ||
| Pubmed | Glycosylation Changes in Serum Proteins Identify Patients with Pancreatic Cancer. | 3.28e-05 | 4 | 82 | 2 | 28244758 | |
| Pubmed | DNA-Dependent protein kinase is not required for efficient lentivirus integration. | 3.28e-05 | 4 | 82 | 2 | 11070027 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 14734561 | ||
| Pubmed | Control of exocytosis by synaptotagmins and otoferlin in auditory hair cells. | 3.28e-05 | 4 | 82 | 2 | 20926654 | |
| Pubmed | ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. | 3.28e-05 | 4 | 82 | 2 | 23548269 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 3.38e-05 | 857 | 82 | 10 | 25609649 | |
| Pubmed | 3.63e-05 | 157 | 82 | 5 | 30186101 | ||
| Interaction | SMC5 interactions | CUL4B SNRPGP15 PRAM1 ELOA PARP1 SETD2 ARID1B BBX WIZ MAP1B CDK12 RSL1D1 ZC3H15 STAU2 CAST RBM15B EIF5B FARSB MSL1 CHD7 XRCC5 SNRPG | 4.75e-11 | 1000 | 82 | 22 | int:SMC5 |
| Interaction | MECP2 interactions | ELOA PARP1 SP100 SETD2 ARID1B BBX WIZ MAP1A MAP1B CDK12 ZC3H15 DHX37 APOOL STAU2 RBM15B EIF5B CHD2 CHD7 XRCC5 SNRPG DHX8 DNMT3A | 5.46e-09 | 1287 | 82 | 22 | int:MECP2 |
| Interaction | FBL interactions | CUL4B ELOA FZR1 SP100 WIZ RSL1D1 ZC3H15 DHX37 STAU2 EIF5B SECISBP2 UTP20 RPL7 PXK PRRC2B | 3.90e-08 | 639 | 82 | 15 | int:FBL |
| Interaction | HNF1B interactions | 7.89e-08 | 190 | 82 | 9 | int:HNF1B | |
| Interaction | H3C1 interactions | CUL4B ELOA PARP1 SETD2 BBX WIZ CCNB3 RSL1D1 DHX37 WDR87 CAST MSL1 CHD7 XRCC5 SNRPG RAC1 DNMT3A | 1.03e-07 | 901 | 82 | 17 | int:H3C1 |
| Interaction | SOX2 interactions | CUL4B ELOA PARP1 FZR1 SETD2 ARID1B WIZ SOX21 ZFHX4 MAP1A MAP1B ZNF608 CDK12 RSL1D1 STAU2 EIF5B MSL1 CHD7 XRCC5 PRRC2B RAC1 | 1.62e-07 | 1422 | 82 | 21 | int:SOX2 |
| Interaction | PAF1 interactions | 2.17e-07 | 214 | 82 | 9 | int:PAF1 | |
| Interaction | CBX3 interactions | CUL4B RYBP ELOA PARP1 SP100 SETD2 BBX WIZ CDK12 EIF5B MSL1 CHD7 PRRC2B DHX8 | 3.09e-07 | 646 | 82 | 14 | int:CBX3 |
| Interaction | NAA40 interactions | ELOA PARP1 SETD2 WIZ MAP1A MAP1B CDK12 RSL1D1 ZC3H15 STAU2 CAST EIF5B FARSB XRCC5 HERC4 RPL7 PRRC2B | 3.29e-07 | 978 | 82 | 17 | int:NAA40 |
| Interaction | CTR9 interactions | 4.45e-07 | 233 | 82 | 9 | int:CTR9 | |
| Interaction | POU5F1 interactions | CUL4B RYBP PRAM1 PARP1 ARID1B SOX21 ATR RSL1D1 EIF5B CHD7 XRCC5 PRRC2B DNMT3A | 6.35e-07 | 584 | 82 | 13 | int:POU5F1 |
| Interaction | NCL interactions | CUL4B PARP1 FZR1 SETD2 GZF1 WIZ RSL1D1 ZC3H15 WDR87 EIF5B XRCC5 SNRPG RPL7 PRRC2B RAC1 | 6.79e-07 | 798 | 82 | 15 | int:NCL |
| Interaction | GATA3 interactions | 9.38e-07 | 187 | 82 | 8 | int:GATA3 | |
| Interaction | SOX7 interactions | 1.03e-06 | 82 | 82 | 6 | int:SOX7 | |
| Interaction | SIRT7 interactions | CUL4B ATR MAP1B RSL1D1 DHX37 MCM3AP EIF5B UTP20 CHD2 CHD7 XRCC5 RPL7 PRRC2B DHX8 | 1.66e-06 | 744 | 82 | 14 | int:SIRT7 |
| Interaction | MYCN interactions | CUL4B PARP1 SETD2 ARID1B BBX MAP1B CDK12 RSL1D1 DHX37 STAU2 RBM15B EIF5B CHD2 CHD7 XRCC5 SNRPG RPL7 PRRC2B DNMT3A | 1.90e-06 | 1373 | 82 | 19 | int:MYCN |
| Interaction | RPS6 interactions | CUL4B MAPKAP1 ELOA FZR1 BBX GZF1 WIZ CDK12 RSL1D1 DHX37 STAU2 EIF5B UTP20 RPL7 RAC1 | 2.11e-06 | 874 | 82 | 15 | int:RPS6 |
| Interaction | TERF2IP interactions | ELOA PARP1 SP100 SETD2 BBX WIZ ZNF608 CDK12 CHD7 XRCC5 DHX8 DNMT3A | 2.29e-06 | 552 | 82 | 12 | int:TERF2IP |
| Interaction | ERG interactions | 3.50e-06 | 223 | 82 | 8 | int:ERG | |
| Interaction | H3C3 interactions | 5.10e-06 | 495 | 82 | 11 | int:H3C3 | |
| Interaction | NXF1 interactions | CEP350 CUL4B PARP1 FZR1 SP100 WIZ MAP1A MAP1B RSL1D1 MCM3AP STAU2 RBM15B FARSB ALG8 MSL1 HERC4 PRRC2B DHX8 | 5.99e-06 | 1345 | 82 | 18 | int:NXF1 |
| Interaction | PAX8 interactions | 6.07e-06 | 111 | 82 | 6 | int:PAX8 | |
| Interaction | EGR2 interactions | 6.23e-06 | 171 | 82 | 7 | int:EGR2 | |
| Interaction | VSX1 interactions | 7.25e-06 | 66 | 82 | 5 | int:VSX1 | |
| Interaction | TBXT interactions | 7.83e-06 | 116 | 82 | 6 | int:TBXT | |
| Interaction | ZNF330 interactions | 1.31e-05 | 446 | 82 | 10 | int:ZNF330 | |
| Interaction | RPLP0 interactions | CUL4B PARP1 FZR1 BBX GZF1 CDK12 RSL1D1 DHX37 STAU2 EIF5B FARSB RPL7 | 1.40e-05 | 660 | 82 | 12 | int:RPLP0 |
| Interaction | GATA2 interactions | 1.67e-05 | 199 | 82 | 7 | int:GATA2 | |
| Interaction | UHRF2 interactions | 1.73e-05 | 200 | 82 | 7 | int:UHRF2 | |
| Interaction | LEO1 interactions | 1.75e-05 | 278 | 82 | 8 | int:LEO1 | |
| Interaction | FEV interactions | 1.90e-05 | 203 | 82 | 7 | int:FEV | |
| Interaction | H2BC8 interactions | 2.11e-05 | 576 | 82 | 11 | int:H2BC8 | |
| Interaction | NPM1 interactions | CUL4B ADGB PARP1 FZR1 SETD2 GZF1 ATR MAP1B RSL1D1 ZC3H15 DHX37 WDR87 STAU2 XRCC5 RPL7 PRRC2B | 2.29e-05 | 1201 | 82 | 16 | int:NPM1 |
| Interaction | RPL13A interactions | FZR1 BBX GZF1 MAP1B CDK12 RSL1D1 STAU2 HERC4 RPL7 PRRC2B DHX8 | 2.67e-05 | 591 | 82 | 11 | int:RPL13A |
| Interaction | CDC73 interactions | 2.70e-05 | 386 | 82 | 9 | int:CDC73 | |
| Interaction | HAPSTR1 interactions | CUL4B PARP1 ARID1B BBX SOX21 ZFHX4 MAP1B DHX37 MCM3AP EIF5B FARSB ALG8 MSL1 | 2.84e-05 | 829 | 82 | 13 | int:HAPSTR1 |
| Interaction | IFI16 interactions | ELOA PARP1 SP100 MAP1B RSL1D1 ZC3H15 DHX37 MCM3AP UTP20 XRCC5 RPL7 DHX8 | 3.04e-05 | 714 | 82 | 12 | int:IFI16 |
| Interaction | SRPK2 interactions | SNRPGP15 SETD2 SYCP2 ZFHX4 OTOF CDK12 RSL1D1 RBM15B CHD2 XRCC5 PRRC2B DHX8 | 3.17e-05 | 717 | 82 | 12 | int:SRPK2 |
| Interaction | WDR5 interactions | CUL4B SNRPGP15 MAPKAP1 RYBP PARP1 FZR1 KANSL1 ZNF608 RSL1D1 ZC3H15 APOOL MSL1 CHD7 XRCC5 RPL7 | 3.32e-05 | 1101 | 82 | 15 | int:WDR5 |
| Interaction | NFIX interactions | 3.89e-05 | 227 | 82 | 7 | int:NFIX | |
| Interaction | HECTD1 interactions | ELOA PARP1 MAP1B CDK12 RSL1D1 DHX37 STAU2 RBM15B EXO1 FARSB UTP20 XRCC5 RPL7 DHX8 | 3.94e-05 | 984 | 82 | 14 | int:HECTD1 |
| Interaction | NUP43 interactions | SETD2 ARID1B BBX KANSL1 ZNF608 CDK12 RSL1D1 MCM3AP UTP20 MSL1 DHX8 | 4.44e-05 | 625 | 82 | 11 | int:NUP43 |
| Interaction | GPATCH4 interactions | 4.47e-05 | 232 | 82 | 7 | int:GPATCH4 | |
| Interaction | H3-3A interactions | ELOA PARP1 BBX WIZ DHX37 ZBTB40 CHD2 MSL1 CHD7 XRCC5 DHX8 DNMT3A | 4.84e-05 | 749 | 82 | 12 | int:H3-3A |
| Interaction | NIFK interactions | 6.35e-05 | 431 | 82 | 9 | int:NIFK | |
| Interaction | TLX1 interactions | 7.98e-05 | 175 | 82 | 6 | int:TLX1 | |
| Interaction | RPL14 interactions | 8.23e-05 | 554 | 82 | 10 | int:RPL14 | |
| Interaction | EN1 interactions | 8.64e-05 | 110 | 82 | 5 | int:EN1 | |
| Interaction | MAGEB2 interactions | 8.73e-05 | 349 | 82 | 8 | int:MAGEB2 | |
| Interaction | PTEN interactions | CUL4B RYBP RFTN1 PARP1 FZR1 BBX RSL1D1 ZC3H15 CCNE2 STAU2 FARSB XRCC5 RPL7 | 9.09e-05 | 929 | 82 | 13 | int:PTEN |
| Interaction | YY1 interactions | 9.44e-05 | 454 | 82 | 9 | int:YY1 | |
| Interaction | PYHIN1 interactions | 1.04e-04 | 358 | 82 | 8 | int:PYHIN1 | |
| Interaction | AFF4 interactions | 1.07e-04 | 115 | 82 | 5 | int:AFF4 | |
| Interaction | RNF113A interactions | BBX GZF1 RSL1D1 MCM3AP STAU2 EIF5B UTP20 MSL1 XRCC5 RPL7 PRRC2B | 1.10e-04 | 692 | 82 | 11 | int:RNF113A |
| Interaction | THRB interactions | 1.12e-04 | 186 | 82 | 6 | int:THRB | |
| Interaction | DDRGK1 interactions | SNRPGP15 ELOA PARP1 ATR CDK12 RSL1D1 ZC3H15 DHX37 STAU2 EIF5B UTP20 PIPSL XRCC5 RPL7 DHX8 | 1.38e-04 | 1249 | 82 | 15 | int:DDRGK1 |
| Interaction | NXF2 interactions | 1.43e-04 | 65 | 82 | 4 | int:NXF2 | |
| Interaction | DDX23 interactions | 1.44e-04 | 480 | 82 | 9 | int:DDX23 | |
| Interaction | NANOG interactions | 1.46e-04 | 481 | 82 | 9 | int:NANOG | |
| Interaction | MTF1 interactions | 1.46e-04 | 123 | 82 | 5 | int:MTF1 | |
| Interaction | MLLT1 interactions | 1.46e-04 | 123 | 82 | 5 | int:MLLT1 | |
| Interaction | ZNF346 interactions | 1.49e-04 | 377 | 82 | 8 | int:ZNF346 | |
| Interaction | CENPA interactions | 1.49e-04 | 377 | 82 | 8 | int:CENPA | |
| Interaction | DCAF4 interactions | 1.51e-04 | 378 | 82 | 8 | int:DCAF4 | |
| Interaction | PAX7 interactions | 1.52e-04 | 124 | 82 | 5 | int:PAX7 | |
| Interaction | PHIP interactions | 1.53e-04 | 197 | 82 | 6 | int:PHIP | |
| Interaction | USP36 interactions | 1.56e-04 | 599 | 82 | 10 | int:USP36 | |
| Interaction | SNRNP70 interactions | CUL4B ELOA FZR1 BBX MAP1B CDK12 RSL1D1 ZC3H15 RBM15B EIF5B SNRPG RPL7 DHX8 | 1.61e-04 | 984 | 82 | 13 | int:SNRNP70 |
| Interaction | TUBG1 interactions | 1.63e-04 | 382 | 82 | 8 | int:TUBG1 | |
| Interaction | POLR1G interactions | 1.65e-04 | 489 | 82 | 9 | int:POLR1G | |
| Interaction | GNL2 interactions | 1.75e-04 | 386 | 82 | 8 | int:GNL2 | |
| Interaction | ANAPC15 interactions | 1.76e-04 | 128 | 82 | 5 | int:ANAPC15 | |
| Interaction | SRSF6 interactions | 2.04e-04 | 503 | 82 | 9 | int:SRSF6 | |
| Interaction | EED interactions | CUL4B RYBP PARP1 WIZ MAP1B RSL1D1 EIF5B FARSB UTP20 CHD2 CHD7 XRCC5 SNRPG RPL7 RAC1 DNMT3A | 2.04e-04 | 1445 | 82 | 16 | int:EED |
| Interaction | PCGF1 interactions | 2.05e-04 | 208 | 82 | 6 | int:PCGF1 | |
| Interaction | UHRF1 interactions | 2.05e-04 | 208 | 82 | 6 | int:UHRF1 | |
| Interaction | MYB interactions | 2.11e-04 | 133 | 82 | 5 | int:MYB | |
| Interaction | KAT6A interactions | 2.26e-04 | 510 | 82 | 9 | int:KAT6A | |
| Interaction | SP7 interactions | 2.40e-04 | 304 | 82 | 7 | int:SP7 | |
| Interaction | MEN1 interactions | CUL4B ARID1B WIZ KANSL1 ZNF608 RSL1D1 DHX37 MCM3AP EIF5B UTP20 XRCC5 SNRPG DHX8 | 2.50e-04 | 1029 | 82 | 13 | int:MEN1 |
| Interaction | FZR1 interactions | PARP1 FZR1 KANSL1 MAP1B CDK12 RSL1D1 ZC3H15 DHX37 STAU2 CAST EIF5B FARSB XRCC5 RPL7 | 2.51e-04 | 1172 | 82 | 14 | int:FZR1 |
| Interaction | PIP4K2A interactions | 2.51e-04 | 216 | 82 | 6 | int:PIP4K2A | |
| Interaction | SNRNP40 interactions | 2.56e-04 | 637 | 82 | 10 | int:SNRNP40 | |
| Interaction | RPL19 interactions | 2.59e-04 | 638 | 82 | 10 | int:RPL19 | |
| Interaction | NOP58 interactions | 2.65e-04 | 309 | 82 | 7 | int:NOP58 | |
| Interaction | RBM39 interactions | CUL4B PARP1 FZR1 SP100 SETD2 MAP1B CDK12 RSL1D1 STAU2 XRCC5 RPL7 RAC1 DHX8 | 2.82e-04 | 1042 | 82 | 13 | int:RBM39 |
| Interaction | MKI67 interactions | 2.93e-04 | 648 | 82 | 10 | int:MKI67 | |
| Interaction | SNIP1 interactions | 2.94e-04 | 417 | 82 | 8 | int:SNIP1 | |
| Interaction | CAPN10 interactions | 2.96e-04 | 32 | 82 | 3 | int:CAPN10 | |
| Interaction | H1-4 interactions | 3.23e-04 | 656 | 82 | 10 | int:H1-4 | |
| Interaction | RPL8 interactions | 3.39e-04 | 539 | 82 | 9 | int:RPL8 | |
| Interaction | RBM25 interactions | 3.46e-04 | 323 | 82 | 7 | int:RBM25 | |
| Interaction | SALL3 interactions | 3.55e-04 | 34 | 82 | 3 | int:SALL3 | |
| Interaction | XRCC6 interactions | CUL4B ELOA PARP1 FZR1 BBX WIZ MAP1B CDK12 FARSB CHD7 XRCC5 DHX8 | 3.59e-04 | 928 | 82 | 12 | int:XRCC6 |
| Interaction | RC3H2 interactions | MAP1B CDK12 RSL1D1 DHX37 STAU2 EIF5B SECISBP2 XRCC5 RPL7 PRRC2B | 3.69e-04 | 667 | 82 | 10 | int:RC3H2 |
| Interaction | PAX2 interactions | 4.01e-04 | 85 | 82 | 4 | int:PAX2 | |
| Interaction | IRF4 interactions | 4.01e-04 | 85 | 82 | 4 | int:IRF4 | |
| Interaction | COIL interactions | 4.03e-04 | 552 | 82 | 9 | int:COIL | |
| Interaction | RC3H1 interactions | 4.14e-04 | 677 | 82 | 10 | int:RC3H1 | |
| Interaction | RPL31 interactions | 4.29e-04 | 680 | 82 | 10 | int:RPL31 | |
| Cytoband | 8q21.11 | 1.74e-05 | 28 | 82 | 3 | 8q21.11 | |
| Cytoband | 20p12.3 | 4.73e-04 | 18 | 82 | 2 | 20p12.3 | |
| GeneFamily | C2 domain containing|Calpains | 6.80e-04 | 15 | 47 | 2 | 975 | |
| GeneFamily | DEAH-box helicases | 7.75e-04 | 16 | 47 | 2 | 500 | |
| GeneFamily | DNA helicases | 8.77e-04 | 17 | 47 | 2 | 1167 | |
| GeneFamily | Cyclins | 2.39e-03 | 28 | 47 | 2 | 473 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 5.09e-03 | 134 | 47 | 3 | 861 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CEP350 RYBP RFTN1 SP100 SETD2 BBX ATR MAP1B STAU2 VPS13A UTP20 SUCO HERC4 | 2.44e-06 | 856 | 82 | 13 | M4500 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | PARP1 SP100 ATR ZC3H15 CCNE2 POLG EXO1 EIF5B UTP20 XRCC5 SNRPG | 2.47e-05 | 761 | 82 | 11 | M11961 |
| Coexpression | GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP | 3.15e-05 | 192 | 82 | 6 | M7558 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN | 3.24e-05 | 193 | 82 | 6 | M3137 | |
| Coexpression | BASAKI_YBX1_TARGETS_DN | 3.52e-05 | 398 | 82 | 8 | M14877 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP | 3.96e-05 | 200 | 82 | 6 | M4590 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_TREG_UP | 3.96e-05 | 200 | 82 | 6 | M3232 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN | 3.96e-05 | 200 | 82 | 6 | M5271 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP | 3.96e-05 | 200 | 82 | 6 | M3774 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP | 3.96e-05 | 200 | 82 | 6 | M5610 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CEP350 PACS1 RFTN1 PARP1 SETD2 TCF7 BBX KANSL1 ATR GPCPD1 SECISBP2 CHD2 XRCC5 RPL7 PRRC2B | 5.37e-05 | 1492 | 82 | 15 | M40023 |
| Coexpression | NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON | 6.00e-05 | 132 | 82 | 5 | M13954 | |
| Coexpression | RAO_BOUND_BY_SALL4 | 7.80e-05 | 226 | 82 | 6 | M2521 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.06e-04 | 466 | 82 | 8 | M13522 | |
| Coexpression | RAO_BOUND_BY_SALL4 | 1.27e-04 | 247 | 82 | 6 | MM1081 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.06e-05 | 532 | 80 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | SYCP2 BBX KANSL1 ATR CCNB3 CDK12 HECTD2 CCNE2 VPS13A EXO1 CHD2 ANKRD12 | 3.21e-05 | 776 | 80 | 12 | gudmap_developingGonad_e14.5_ ovary_1000 |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.16e-09 | 197 | 82 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.56e-09 | 200 | 82 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.56e-08 | 199 | 82 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.06e-06 | 181 | 82 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.32e-06 | 188 | 82 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.84e-06 | 199 | 82 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | ileum-Epithelial_Stem_Cells|ileum / shred on tissue and cell subclass | 3.65e-06 | 126 | 82 | 5 | a8ed48cbd1e207fd1aaad454fda9f329eb22aa83 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.71e-06 | 154 | 82 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.71e-06 | 154 | 82 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-05 | 164 | 82 | 5 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.40e-05 | 166 | 82 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-05 | 168 | 82 | 5 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-05 | 168 | 82 | 5 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.06e-05 | 180 | 82 | 5 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 182 | 82 | 5 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.23e-05 | 183 | 82 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.35e-05 | 185 | 82 | 5 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.35e-05 | 185 | 82 | 5 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.35e-05 | 185 | 82 | 5 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.35e-05 | 185 | 82 | 5 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 2.48e-05 | 187 | 82 | 5 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.48e-05 | 187 | 82 | 5 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 2.54e-05 | 188 | 82 | 5 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 188 | 82 | 5 | 0eca3dc93724e23b71e687fc24fa9f1e89bdef6a | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 188 | 82 | 5 | 9ce3e1fffce87ad19812ecbf9b7f9935a975d676 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.60e-05 | 189 | 82 | 5 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.60e-05 | 189 | 82 | 5 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-05 | 189 | 82 | 5 | fe958fdf9963c2dfe270f67f0da36b3264d0017c | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.60e-05 | 189 | 82 | 5 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.67e-05 | 190 | 82 | 5 | 549d813a8f23b175875e53347928941f143e236c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.67e-05 | 190 | 82 | 5 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.74e-05 | 191 | 82 | 5 | 649fcb62ad15de2f83e61591e43923a717664ae7 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.74e-05 | 191 | 82 | 5 | 9621e22e14ea069f22713947c9faa2d882abe5fe | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-05 | 191 | 82 | 5 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-05 | 191 | 82 | 5 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-05 | 191 | 82 | 5 | b55500eb416f4f339031acad16b2737e5b891d8e | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.74e-05 | 191 | 82 | 5 | 6a8fc9dc1a4c7115862e8f20204fa2f95e50e22f | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-05 | 192 | 82 | 5 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.81e-05 | 192 | 82 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-05 | 192 | 82 | 5 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.88e-05 | 193 | 82 | 5 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 3.10e-05 | 196 | 82 | 5 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 3.10e-05 | 196 | 82 | 5 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.18e-05 | 197 | 82 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.25e-05 | 198 | 82 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 3.25e-05 | 198 | 82 | 5 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-05 | 198 | 82 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-05 | 199 | 82 | 5 | 1b74f6fbf2628f335ba5eb49b679d2f72068bbbe | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-05 | 199 | 82 | 5 | a660f7373fca03929234cbd936735f97883fb689 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.33e-05 | 199 | 82 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.41e-05 | 200 | 82 | 5 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-OPC_related-Oligodendrocyte/OPC|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-05 | 200 | 82 | 5 | 80cec67b7557465320a847ba959a8a13f7c51566 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 3.41e-05 | 200 | 82 | 5 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 3.41e-05 | 200 | 82 | 5 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-OPC_related|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-05 | 200 | 82 | 5 | 8dafb90b418f91a0fb56c97db06233d3eca358dc | |
| ToppCell | severe-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.41e-05 | 200 | 82 | 5 | f74bdabadca8ad6dae1b6e6812c66325aac50db0 | |
| ToppCell | Transverse-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 3.41e-05 | 200 | 82 | 5 | d89d3c16406d77cb08e1aa00d7df6887a692c337 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Sla|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-04 | 132 | 82 | 4 | ddebc0b233fdbb73ceb70187945bbed8fd273f2a | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Macc1_Lrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.37e-04 | 142 | 82 | 4 | d08e1880425d285c4433014fe0242ac7ff7734af | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-04 | 148 | 82 | 4 | d5cace5605bff2bb8248fadb51f2dad7539930ba | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 151 | 82 | 4 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 151 | 82 | 4 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-04 | 154 | 82 | 4 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-04 | 154 | 82 | 4 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-04 | 155 | 82 | 4 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-04 | 155 | 82 | 4 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-04 | 156 | 82 | 4 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.97e-04 | 156 | 82 | 4 | cea7b4f133272499e77ed451db91f699cff6a4bb | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 1.97e-04 | 156 | 82 | 4 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.22e-04 | 161 | 82 | 4 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-04 | 163 | 82 | 4 | e526104a3a574ee860078ce7c049e7fec9443f37 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.44e-04 | 165 | 82 | 4 | 6799a6580c667738995cceb31cbf1c7fbdc4ff84 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.44e-04 | 165 | 82 | 4 | 8329d780f244bc31344443b29e5a00529a016662 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.50e-04 | 166 | 82 | 4 | a7ac5a414e3e2ff01f1c452c0a85048b17cba0b6 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 2.50e-04 | 166 | 82 | 4 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-04 | 167 | 82 | 4 | 38b1f052d663fa8f407c54bdd2060216f26feb0e | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 168 | 82 | 4 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.80e-04 | 171 | 82 | 4 | 2991096336eea87740708360e34f84a00cb2eff2 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.80e-04 | 171 | 82 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-04 | 171 | 82 | 4 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-04 | 171 | 82 | 4 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.92e-04 | 173 | 82 | 4 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-04 | 173 | 82 | 4 | 27ae126c720f20d1fe116abbcd358e4cff8baf6b | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-04 | 174 | 82 | 4 | f1510b0f7771936adf29ae3572feab55db31832b | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-04 | 174 | 82 | 4 | 5d5d2fc60afff47f997751e8e9ca1367a22d19ec | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 176 | 82 | 4 | 5201f003192c033655ba47f0faf8c47a96eae03d | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.26e-04 | 178 | 82 | 4 | 65508833f9f7fb03d54b62cec9a1337a06b65031 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|normal_Lymph_Node / Location, Cell class and cell subclass | 3.26e-04 | 178 | 82 | 4 | d75057e7463558a0d3cebde3c30befbf4704dd9a | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 178 | 82 | 4 | d9eba884e18a0c89bdc70c194bfe4d62cca164fa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 178 | 82 | 4 | b03aa1de9d20895ebad55f6fcd6fe7a49335db5a | |
| ToppCell | 3'_v3|World / Manually curated celltypes from each tissue | 3.26e-04 | 178 | 82 | 4 | 42502f14d9c756df8104900ac6484477b885d3d9 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 178 | 82 | 4 | 0f5cf34609df791c8baebfdc6590f6eb4dbe0509 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-04 | 178 | 82 | 4 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 178 | 82 | 4 | 408e41c853f608965cef9111fb87fdc311cdc7a8 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.26e-04 | 178 | 82 | 4 | 61363c3365d3e191c47be1b2a35fa8afbfa64ff2 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.33e-04 | 179 | 82 | 4 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | P03-Epithelial-airway_epithelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.47e-04 | 181 | 82 | 4 | 1ea21d860d4d7abab3e21e130a16d044006656ee | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-club_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.47e-04 | 181 | 82 | 4 | 60a91587c59029a34e7bec1255083337fe21b72a | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-4|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.47e-04 | 181 | 82 | 4 | 51d91b923920463245e95d65c6a5197e21d34d73 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.54e-04 | 182 | 82 | 4 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 6.08e-06 | 197 | 80 | 7 | 1075_DN | |
| Drug | Demecarium bromide [56-94-0]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 6.28e-06 | 198 | 80 | 7 | 6269_DN | |
| Drug | AC1NDK7X | 1.39e-05 | 87 | 80 | 5 | CID004627201 | |
| Drug | IDPN | 4.56e-05 | 20 | 80 | 3 | CID000008149 | |
| Drug | CPG-oligonucleotide | 4.70e-05 | 184 | 80 | 6 | ctd:C408982 | |
| Drug | 17-AAG; Down 200; 1uM; ssMCF7; HG-U133A | 5.78e-05 | 191 | 80 | 6 | 521_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 6.13e-05 | 193 | 80 | 6 | 1081_DN | |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Up 200; 100uM; MCF7; HT_HG-U133A_EA | 6.13e-05 | 193 | 80 | 6 | 881_UP | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 6.31e-05 | 194 | 80 | 6 | 3169_DN | |
| Drug | clofibrate; Up 200; 150uM; MCF7; HG-U133A | 6.31e-05 | 194 | 80 | 6 | 263_UP | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 6159_DN | |
| Drug | Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; HL60; HG-U133A | 6.67e-05 | 196 | 80 | 6 | 2046_UP | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; HL60; HT_HG-U133A | 6.67e-05 | 196 | 80 | 6 | 1851_DN | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; HL60; HG-U133A | 6.86e-05 | 197 | 80 | 6 | 1577_DN | |
| Drug | Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; PC3; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 4228_UP | |
| Drug | Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 3483_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; MCF7; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 6046_DN | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 6271_DN | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 7233_DN | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; PC3; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 5879_DN | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HG-U133A | 7.46e-05 | 200 | 80 | 6 | 1953_DN | |
| Disease | Intellectual Disability | PACS1 PARP1 SETD2 PTCHD1 KANSL1 MAP1B ZBTB40 FARSB RAC1 DNMT3A | 3.27e-07 | 447 | 79 | 10 | C3714756 |
| Disease | age at menopause | 1.69e-05 | 302 | 79 | 7 | EFO_0004704 | |
| Disease | Mental Retardation, Psychosocial | 3.68e-05 | 139 | 79 | 5 | C0025363 | |
| Disease | Profound Mental Retardation | 3.68e-05 | 139 | 79 | 5 | C0020796 | |
| Disease | Mental deficiency | 3.68e-05 | 139 | 79 | 5 | C0917816 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 6.45e-05 | 80 | 79 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | smoking status measurement, Crohn's disease | 1.47e-04 | 7 | 79 | 2 | EFO_0000384, EFO_0006527 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.47e-04 | 7 | 79 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | nasopharynx carcinoma (is_marker_for) | 2.11e-04 | 43 | 79 | 3 | DOID:9261 (is_marker_for) | |
| Disease | peanut allergy measurement, parental genotype effect measurement | 3.83e-04 | 11 | 79 | 2 | EFO_0005939, EFO_0007017 | |
| Disease | red blood cell density measurement | 5.70e-04 | 880 | 79 | 9 | EFO_0007978 | |
| Disease | stomach cancer (is_marker_for) | 5.84e-04 | 142 | 79 | 4 | DOID:10534 (is_marker_for) | |
| Disease | intellectual disability (implicated_via_orthology) | 1.09e-03 | 75 | 79 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Parkinson's disease (is_implicated_in) | 1.13e-03 | 76 | 79 | 3 | DOID:14330 (is_implicated_in) | |
| Disease | Cannabis use, age at onset | 1.18e-03 | 19 | 79 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | total blood protein measurement | 1.31e-03 | 449 | 79 | 6 | EFO_0004536 | |
| Disease | Epilepsy, Cryptogenic | 1.40e-03 | 82 | 79 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.40e-03 | 82 | 79 | 3 | C0751111 | |
| Disease | Aura | 1.40e-03 | 82 | 79 | 3 | C0236018 | |
| Disease | Autism Spectrum Disorders | 1.56e-03 | 85 | 79 | 3 | C1510586 | |
| Disease | Seckel syndrome | 1.58e-03 | 22 | 79 | 2 | C0265202 | |
| Disease | reticulocyte measurement | 1.99e-03 | 1053 | 79 | 9 | EFO_0010700 | |
| Disease | Neurodevelopmental Disorders | 2.02e-03 | 93 | 79 | 3 | C1535926 | |
| Disease | Autosomal Dominant Parkinsonism | 2.56e-03 | 28 | 79 | 2 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 2.56e-03 | 28 | 79 | 2 | C0752097 | |
| Disease | glaucoma (biomarker_via_orthology) | 2.56e-03 | 28 | 79 | 2 | DOID:1686 (biomarker_via_orthology) | |
| Disease | gastric adenocarcinoma (is_marker_for) | 2.56e-03 | 28 | 79 | 2 | DOID:3717 (is_marker_for) | |
| Disease | Parkinsonism, Experimental | 2.56e-03 | 28 | 79 | 2 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 2.56e-03 | 28 | 79 | 2 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 2.56e-03 | 28 | 79 | 2 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 2.56e-03 | 28 | 79 | 2 | C0242423 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 2.56e-03 | 28 | 79 | 2 | C1868675 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KETLPSKPVKKEKEQ | 646 | Q9NYV4 | |
| ILDAKPPKKKVKSRE | 521 | Q8WY36 | |
| KPRKSTAEKPKVKEI | 456 | Q9Y6K1 | |
| SPKKTKEKSPAKRII | 131 | Q32M84 | |
| LKAPEKSDKVPKEKA | 351 | Q8N7X0 | |
| SKDKLDKKKEVVKPP | 201 | Q9H116 | |
| LKLFRPKKLLPKAFK | 376 | Q9BQL6 | |
| EESLPPIKKEEKKKT | 211 | A7E2U8 | |
| KSTSPVKLKTFKKIP | 336 | O96020 | |
| EKPKQASKFDKLPIK | 1846 | Q8NFD5 | |
| KPLSLKEKTKDEPLK | 996 | Q6UB98 | |
| SLLKLKSEADKPKPK | 1041 | Q6UB98 | |
| RSKAKKDPKEPKEPK | 646 | Q9P2D1 | |
| KAIEKEKKVTALPPK | 41 | O75185 | |
| EKSLIKEPLPFKEEK | 516 | Q8WWL7 | |
| KEPLPFKEEKVSLKK | 521 | Q8WWL7 | |
| KPSIKKETLLKKPLA | 901 | Q8WWL7 | |
| KPLEEPKHETKKLKN | 696 | Q8NDT2 | |
| DLKKKIPSLSFSPLK | 131 | Q6ZSC3 | |
| IEKLKEKKLTPITYP | 126 | P63000 | |
| RPCLPQKIKKKESKF | 431 | Q14699 | |
| KKLKVKKQDRIFPPE | 346 | P09874 | |
| KFPLELKKRLKKLSE | 311 | Q7Z4I7 | |
| DTKPELKKISKPDLK | 451 | P78559 | |
| EIKKLPKDAKKSSTP | 731 | P46821 | |
| KLLKKELPSKDLPKT | 911 | Q5HYC2 | |
| KISPNKKPFSLKEKK | 506 | O60318 | |
| PPYKSKKDLKQKLII | 751 | Q5U5R9 | |
| FPLALYKKLLKKKPS | 816 | Q5GLZ8 | |
| KKVKKEPATASKLPI | 501 | P54098 | |
| NKPFDKIKPPKKLSL | 691 | Q7Z3B3 | |
| KTPVKKLAPEFSKVK | 341 | Q68DK7 | |
| KLAPEFSKVKTKTPK | 346 | Q68DK7 | |
| EKKKEVPAVPETLKK | 6 | P18124 | |
| KIFKIPPQAFKDLKK | 206 | Q68CR7 | |
| EKNKKVPTIFLSKKP | 881 | Q6VY07 | |
| VFKKIPLKPSPSKKL | 396 | A2A3N6 | |
| KFPEKAKSPVKEEVK | 786 | P12036 | |
| KEEVKSPEKAKSPLK | 796 | P12036 | |
| PAVEKPKESKVEAKK | 886 | P12036 | |
| KPTRKISKIPFKVLD | 166 | Q9UM11 | |
| FLFLLKKKIPSPVKL | 766 | Q13535 | |
| EKPPVSITKKKLKKS | 141 | Q9NPB8 | |
| NPDPKKLLKYLKKLS | 46 | Q14241 | |
| KLTDKILPVETDKKP | 1291 | O14647 | |
| DKELIKPKTPKKELE | 1901 | Q5VT06 | |
| KKKKVKPPRTLITED | 281 | Q86X45 | |
| PLTVKPKETIKKEEK | 226 | Q8IY82 | |
| KKEEKVLPKKYTIKP | 236 | Q8IY82 | |
| VPSPKDFLKKHSKEK | 56 | Q8TC29 | |
| DFLKKHSKEKTLPPK | 61 | Q8TC29 | |
| DKKKEKKSLTPAVPV | 126 | P20810 | |
| DRPVKKKKTKPIIFV | 591 | P20807 | |
| APPLSKKEKKPLTKK | 61 | Q8IY37 | |
| KLVIKNFKDKPKLPE | 196 | Q13620 | |
| SKDPVVKPKTEKEKL | 101 | Q14562 | |
| VKPKTEKEKLKELFP | 106 | Q14562 | |
| KKPKIDELKVYPKEL | 1401 | Q9HC10 | |
| SSKEESLPKPKEKTK | 186 | Q6UXV4 | |
| DPYVKVFLLPDKKKK | 176 | Q8N9I0 | |
| KKTKKHLPEPVAIKF | 2506 | O75691 | |
| RKPKTLLKKDKFAFP | 81 | Q9Y651 | |
| LTFLPPSKKKRKEKK | 846 | Q96NR3 | |
| KDSLPKKRPIYEDKK | 436 | O60841 | |
| KPEKDKEISPSVTKK | 91 | Q8N488 | |
| PKKPSKLELSDLSKK | 116 | Q96QH2 | |
| FLPKDVKKEKLSPDI | 111 | Q8NEK8 | |
| KSLFEKKSLKEKPPI | 121 | Q9BPZ7 | |
| REIPKAKKPTSLKKI | 521 | Q96T21 | |
| ILKKKSKPCLIKKEP | 1271 | O95785 | |
| KKDSEKLPPCKKPLS | 801 | Q9UQ84 | |
| KRPSDIKFKPLNKTK | 176 | Q9NSD9 | |
| KKVGKELTEKPKFIL | 131 | Q9BVK2 | |
| TKPEKHPKKEEKISS | 3161 | Q86UP3 | |
| KELYKKKLTSKKPPG | 366 | Q96RL7 | |
| PPELKKFMDKKLSLK | 6 | P62308 | |
| VEKPKLFFKKRPKTI | 281 | Q9NUL3 | |
| KPKIKEEAVKEKSPS | 431 | O76021 | |
| EIKPFKRFLRKKSKP | 371 | Q9H3U7 | |
| SLKEKSKSPKEFAKP | 436 | Q9BX26 | |
| PPELKKFTDKKFSLK | 6 | A8MWD9 | |
| TYIPPKGEKKKKFKD | 751 | P23497 | |
| PIKKPVLKALKVEDK | 941 | Q5JSZ5 | |
| DLIYKAKPKDPFLKK | 236 | Q7Z7A4 | |
| IVEPLKFSPEKKKKR | 1096 | Q9UBS9 | |
| KFIKNVKGPKKLFPD | 601 | Q92543 | |
| EKEAKKPTIKKPLNA | 261 | P36402 | |
| KSTLSKPIPKSDKFK | 556 | Q9BYW2 | |
| KKLKTEKVDPLFTVP | 296 | Q9ULD9 | |
| LPPGFVLKKDKKKEE | 211 | Q8WU90 | |
| KKTQPISKKKEELPL | 2711 | Q6ZQQ6 | |
| SKIKTLFPLIEAKKK | 531 | P13010 | |
| DAPKKKKKRLPVTCD | 796 | Q9NUA8 |